Parvovirus B19 and recipient safety: is it time to do more?
- PMID: 32567077
- DOI: 10.1111/tme.12703
Parvovirus B19 and recipient safety: is it time to do more?
Comment on
-
Parvovirus B19 infection in sickle cell disease: An analysis from the Centers for Disease Control haemoglobinopathy blood surveillance project.Transfus Med. 2020 Jun;30(3):226-230. doi: 10.1111/tme.12671. Epub 2020 Mar 4. Transfus Med. 2020. PMID: 32131139 Free PMC article.
References
REFERENCES
-
- Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 2009;49(suppl 2):1S-29S.
-
- Stramer SL, Dodd RY, for the AABB Transfusion-Transmitted Diseases Emerging Infectious Diseases Subgroup. Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress. Transfusion. 2013;53:2375-2383.
-
- Satake M, Hoshi Y, Taira R, Momose S-Y, Hino S, Tadokoro K. Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion. 2011;51:1887-1895.
-
- Sakata M, Matsubayashi K, Ihara H, et al. Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors. Transfusion. 2013;53:2556-2566.
-
- Kleinman SH, Glynn SA, Lee T-H, et al. Prevalence and quantitation of parvovirus B19 levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion. 2007;47:1756-1764.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical